CD80 and familial pancreatic carcinoma: Some receptors of the B7 family members are not yet identified, and the immunomodulatory mechanisms of the B7 family members in the pancreatic cancer microenvironment and their non-immunological functions have not been fully elucidated, all of which limit their further application.